These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9241022)

  • 21. Anxiety disorders. Part 2: Pharmacotherapy with benzodiazepines.
    Labelle A; Lapierre YD
    Can Fam Physician; 1993 Oct; 39():2205-8; 2211-3. PubMed ID: 8106034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The mechanism of action of benzodiazepine and its consequences for therapy].
    Cugurra F
    Clin Ter; 1992 Apr; 140(4):331-43. PubMed ID: 1350239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rational use of benzodiazepines in the elderly.
    Shorr RI; Robin DW
    Drugs Aging; 1994 Jan; 4(1):9-20. PubMed ID: 7907503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurochemical and pharmacokinetic correlates of the clinical action of benzodiazepine hypnotic drugs.
    Greenblatt DJ; Miller LG; Shader RI
    Am J Med; 1990 Mar; 88(3A):18S-24S. PubMed ID: 1968714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The anxiolytic-like effects of the neurosteroid allopregnanolone: interactions with GABA(A) receptors.
    Brot MD; Akwa Y; Purdy RH; Koob GF; Britton KT
    Eur J Pharmacol; 1997 Apr; 325(1):1-7. PubMed ID: 9151931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GABAA receptor subtype-selective modulators. I. α2/α3-selective agonists as non-sedating anxiolytics.
    Atack JR
    Curr Top Med Chem; 2011; 11(9):1176-202. PubMed ID: 21050172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of radioreceptor assays for the determination of benzodiazepines in biological samples: a review.
    Bruhwyler J; Hassoun A
    J Anal Toxicol; 1992; 16(4):244-52. PubMed ID: 1354272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GABA-A receptors: a viable target for novel anxiolytics?
    Whiting PJ
    Curr Opin Pharmacol; 2006 Feb; 6(1):24-9. PubMed ID: 16359919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of extended-release benzodiazepines in the treatment of anxiety: a risk-benefit evaluation with a focus on extended-release alprazolam.
    Klein E
    J Clin Psychiatry; 2002; 63 Suppl 14():27-33. PubMed ID: 12562116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia.
    Smith MT; Perlis ML; Park A; Smith MS; Pennington J; Giles DE; Buysse DJ
    Am J Psychiatry; 2002 Jan; 159(1):5-11. PubMed ID: 11772681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Psychopharmacology and clinical aspects of benzodiazepine dependence].
    Apelt S; Schmauss C; Emrich HM
    Fortschr Neurol Psychiatr; 1992 Mar; 60(3):104-9. PubMed ID: 1349546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of the benzodiazepine receptor agonist, zolpidem, on palatable fluid consumption in the rat.
    Stanhope KJ; Roe S; Dawson G; Draper F; Jackson A
    Psychopharmacology (Berl); 1993; 111(2):185-9. PubMed ID: 7870950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contribution of specific binding to the central benzodiazepine site to the brain concentrations of two novel benzodiazepine site ligands.
    Pike A; Cook SM; Watt AP; Scott-Stevens P; Rosahl TW; McKernan RM; Pym LJ; Guiblin A; Moyes C; Sohal B; Atack JR
    Biopharm Drug Dispos; 2007 Sep; 28(6):275-82. PubMed ID: 17570124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Use of benzodiazepines in psychiatric emergency situations].
    Leppävuori A
    Duodecim; 2002; 118(3):297-304. PubMed ID: 12233032
    [No Abstract]   [Full Text] [Related]  

  • 35. Benzodiazepines for the treatment of panic disorder and generalized anxiety disorder: clinical issues and future directions.
    Bradwejn J
    Can J Psychiatry; 1993 Nov; 38 Suppl 4():S109-13. PubMed ID: 7905780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sleep disorders and anxiety: biochemical antecedents and pharmacological consequences.
    Leonard BE
    J Psychosom Res; 1994; 38 Suppl 1():69-87. PubMed ID: 7799254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The classification and mechanism of the hypnotics].
    Hashizume Y
    Nihon Rinsho; 1998 Feb; 56(2):510-4. PubMed ID: 9503860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic benzodiazepine administration: effects in vivo and in vitro.
    Miller LG; Greenblatt DJ; Lopez F; Schatzki A; Heller J; Lumpkin M; Shader RI
    Adv Biochem Psychopharmacol; 1990; 46():167-75. PubMed ID: 1981302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Putative benzodiazepine partial agonists demonstrate receptor heterogeneity.
    Chen SW; Chen HA; Davies MF; Loew GH
    Pharmacol Biochem Behav; 1996 Jan; 53(1):87-97. PubMed ID: 8848465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization in rats of the anxiolytic potential of ELB139 [1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydro-imidazol-2-on], a new agonist at the benzodiazepine binding site of the GABAA receptor.
    Langen B; Egerland U; Bernöster K; Dost R; Unverferth K; Rundfeldt C
    J Pharmacol Exp Ther; 2005 Aug; 314(2):717-24. PubMed ID: 15860576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.